122 related articles for article (PubMed ID: 9376207)
1. Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV vaccine efficacy trials.
Fureman I; Meyers K; McLellan AT; Metzger D; Woody G
AIDS Educ Prev; 1997 Aug; 9(4):330-41. PubMed ID: 9376207
[TBL] [Abstract][Full Text] [Related]
2. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
[TBL] [Abstract][Full Text] [Related]
3. Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial.
Pitisuttithum P; Migasena S; Laothai A; Suntharasamai P; Kumpong C; Vanichseni S
J Med Assoc Thai; 1997 Jan; 80(1):47-50. PubMed ID: 9078816
[TBL] [Abstract][Full Text] [Related]
4. Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
Vlahov D; Astemborski J; Solomon L; Galai N; Basarab L; Nelson KE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S265-8. PubMed ID: 7865315
[TBL] [Abstract][Full Text] [Related]
5. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.
Harrison K; Vlahov D; Jones K; Charron K; Clements ML
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):386-90. PubMed ID: 7552502
[TBL] [Abstract][Full Text] [Related]
6. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US.
Priddy FH; Cheng AC; Salazar LF; Frew PM
Int J STD AIDS; 2006 Feb; 17(2):99-102. PubMed ID: 16464270
[TBL] [Abstract][Full Text] [Related]
7. Preparations for AIDS vaccine trials. Recruitment and retention of in- and out-of-treatment injection drug users.
Woody GE; Metzger D; Mulvaney F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S197-9. PubMed ID: 7865300
[No Abstract] [Full Text] [Related]
8. Incentives and disincentives to participate in prophylactic HIV vaccine research.
Jenkins RA; Temoshok LR; Virochsiri K
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):36-42. PubMed ID: 7712233
[TBL] [Abstract][Full Text] [Related]
9. Willingness to participate in HIV vaccine research in a peri-urban South African community.
Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
[TBL] [Abstract][Full Text] [Related]
10. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey.
Starace F; Wagner TM; Luzi AM; Cafaro L; Gallo P; Rezza G
AIDS Care; 2006 Jan; 18(1):66-72. PubMed ID: 16282079
[TBL] [Abstract][Full Text] [Related]
12. [Effects of video information in patients undergoing coronary angiography].
Philippe F; Meney M; Larrazet F; Ben Abderrazak F; Dibie A; Meziane T; Folliguet T; Delahousse P; Lemoine JF; Laborde F
Arch Mal Coeur Vaiss; 2006 Feb; 99(2):95-101. PubMed ID: 16555691
[TBL] [Abstract][Full Text] [Related]
13. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
14. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
15. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
16. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
17. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
[TBL] [Abstract][Full Text] [Related]
18. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.
Van de Ven P; Mao L; Crawford J; Prestage G; Grulich A; Kaldor J; Kippax S
Int J STD AIDS; 2005 Apr; 16(4):314-7. PubMed ID: 15899086
[TBL] [Abstract][Full Text] [Related]
19. Preventive HIV type 1 vaccine clinical trials: a regulatory perspective.
Goldenthal KL; Vaillancourt JM; Geber A; Lucey DR
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S333-40. PubMed ID: 9814962
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]